MicroVision Inc. (MVIS) — RQD Stock Rating Cockpit

The per the Roarable RQD rating, MVIS scores 27 out of 100 and carries a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." The five pillars are:

• Fundamental Cash Engine: 8 / 20. The pillar reflects ROIC of -35% and an FCF yield of 0%. For a prospective investor, this means the business is not currently generating returns on invested capital or free cash flow to shareholders; any valuation must rest on future cash generation rather than current earnings power.
• Whale 13F Flow: 5 / 20. The pillar reflects institutional accumulation and options positioning. The weak score indicates limited institutional support in the source data, which reduces the likelihood of sponsorship from large holders.
• Insider Conviction: 3 / 20. The pillar reflects SEC Form 4 and Congressional PTR cluster flow. This is the lowest pillar and signals weak insider conviction in the source data.
• Macro Regime Fit: 6 / 20. The pillar reflects a beta of 1.0 and sector sensitivity. A beta of 1.0 means the stock is expected to move in line with the broader market, offering no defensive cushion.
• Forensic Balance Sheet: 5 / 20. The pillar reflects an Altman Z-Score of 2.5, a Piotroski F-Score of 3/9, and a Debt/Equity ratio of 0.5. These readings point to meaningful financial fragility relative to healthier issuers.

Taken together, the rating frames MVIS as a high-risk, speculative situation. Upside drivers would need to come from a turnaround in operating economics that the current source data does not show. Valuation tradeoffs are severe: with a market cap of $43.4M against reported net losses in each period shown, the equity is priced on expectations rather than demonstrated earnings. Second-order risk includes the possibility that weak forensic metrics and thin institutional sponsorship amplify downside moves during adverse news.

Per the SEC financials, revenue declined from $7.3M in FY 2023 to $4.7M in FY 2024 and $1.2M in FY 2025, while operating losses remained large in every period. The per the market data section, gross margin is -30%, operating margin is -60%, and net margin is -60%, with ROIC at -35%. The per the Roarable RQD rating, the Altman Z-Score is 2.5 and the Piotroski F-Score is 3/9. Debt/Equity is 0.5 per the same rating, though debt levels in the financials are listed as N/A, so the reported debt figure cannot be independently verified.

Per the recent news section, the headlines center on MicroVision's reaffirmed 2026 revenue outlook and commercial growth and path-to-profitability messaging, flagged as a CATALYST. Conflicting coverage includes reports that the stock fell following the outlook reaffirmation and following Q3 2026 earnings, flagged as RISK WATCH. One headline references Q3 2026 earnings call highlights citing revenue growth, flagged as a CATALYST, though the headline is truncated in the source. A StockInvest.us item is flagged as MARKET WIRE with no stated direction. The per the Butterfly Supply-Chain Graph, no supply-chain links or proprietary signals are recorded; the supply chain field is NONE.

• What are MicroVision's products, customers, and revenue drivers, given that the source data does not describe the business model?
• What explains the sharp decline in revenue from $7.3M to $1.2M across FY 2023 to FY 2025, and what does the reaffirmed 2026 outlook assume?
• Why is the reported debt listed as N/A despite a Debt/Equity ratio of 0.5, and what is the company's actual liability structure?
• What is the path to profitability referenced in news coverage, and what cash runway does the $32.4M cash balance provide against FY 2025's $-59.4M free cash flow outflow?
• Why does the profile report a market capitalization of $0.0B while the market data reports $43.4M?